4//SEC Filing
Talon Therapeutics, Inc. 4
Accession 0000914190-13-000432
CIK 0001140028operating
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:14 PM ET
Size
24.4 KB
Accession
0000914190-13-000432
Insider Transaction Report
Form 4
DEITCHER STEVEN R
DirectorPresident & CEO
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2013-07-17−1,000,000→ 0 totalExercise: $0.64Exp: 2023-01-25→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−1,000,000→ 0 totalExercise: $0.91Exp: 2022-02-17→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Common Stock
2013-07-17−184,192→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−312,500→ 0 totalExercise: $0.76Exp: 2020-02-16→ Common Stock (312,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−87,500→ 0 totalExercise: $0.92Exp: 2020-06-07→ Common Stock (87,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−100,000→ 0 totalExercise: $6.60Exp: 2017-05-21→ Common Stock (100,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−25,000→ 0 totalExercise: $6.96Exp: 2017-08-24→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−162,500→ 0 totalExercise: $4.48Exp: 2017-12-14→ Common Stock (162,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−75,000→ 0 totalExercise: $0.56Exp: 2019-02-24→ Common Stock (75,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−1,635,000→ 0 totalExercise: $0.49Exp: 2020-12-21→ Common Stock (1,635,000 underlying)
Footnotes (2)
- [F1]The reporting person received $0.056 per share plus one contingent value right (CVR) per share in accordance with the terms of a Stock Purchase Agreement by and among Talon Therapeutics, Inc., Spectrum Pharmaceuticals, Inc. and Eagle Acquisition Merger Sub, Inc. dated July 16, 2013 (the "Purchase Agreement"). Each CVR represents the right to receive a maximum future cash payment of approximately $0.968 per CVR from Spectrum based upon the achievement of certain sales and regulatory milestones.
- [F2]This stock option was cancelled pursuant to the terms of the Purchase Agreement.
Documents
Issuer
Talon Therapeutics, Inc.
CIK 0001140028
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001140028
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:14 PM ET
- Size
- 24.4 KB